Cytomegalovirus infection amplifies class I major histocompatibility complex expression on cultured human endothelial cells
- PMID: 8167118
Cytomegalovirus infection amplifies class I major histocompatibility complex expression on cultured human endothelial cells
Abstract
Cytomegalovirus infection, a common complication in immunosuppressed graft recipients, bears an adverse impact on graft survival. Cytomegalovirus enhances the expression of the monotypic determinants of the class I major histocompatibility complex molecule by the endothelium, possibly rendering the endothelial cells more immunogenic and prone to attack by the allogeneic lymphocytes. In the present study, we focused on the effect of cytomegalovirus on the endothelial cell expression of different class I genes, on the relation between the extent of endothelial cell infection and the class I effect, and on the time course of the class I changes induced by the cytomegalovirus infection. Cytomegalovirus infection of primary cultures of human umbilical vein endothelial cells augmented the expression of the A2, A3, and B7 class I major histocompatibility complex genes when compared with uninfected cells. beta 2 microglobulin upregulation by the infected cells paralleled the changes in specific class I expression; this effect was significant only after 7 days after infection. Double immunocytochemical staining and fluorescence-activated cell sorter analysis revealed that the class I enhancement was uniform throughout the umbilical vein endothelial cell monolayer and not restricted to the cells that expressed cytomegalovirus early or late antigens. Ultraviolet-inactivated supernatants from infected umbilical vein endothelial cell did not increase class I expression on uninfected cells. In conclusion, cytomegalovirus might affect graft survival by amplifying the changes in class I expression beyond the sites of viral replication.
Similar articles
-
Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.J Reprod Immunol. 2004 Jun;62(1-2):3-15. doi: 10.1016/j.jri.2003.11.005. J Reprod Immunol. 2004. PMID: 15288176
-
Cytomegalovirus induces class II expression in rat heart endothelial cells.J Heart Lung Transplant. 1993 Jul-Aug;12(4):644-51. J Heart Lung Transplant. 1993. PMID: 8396436
-
Low multiplicity cytomegalovirus infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology.J Heart Lung Transplant. 1997 Oct;16(10):1035-45. J Heart Lung Transplant. 1997. PMID: 9361246
-
Cytomegalovirus and transcriptional down-regulation of major histocompatibility complex class II expression.Semin Immunol. 2001 Feb;13(1):11-8. doi: 10.1006/smim.2001.0291. Semin Immunol. 2001. PMID: 11289795 Review.
-
Role of beta 2-microglobulin in cytomegalovirus infection.Scand J Rheumatol Suppl. 1990;87:98-101; discussion 101. doi: 10.3109/03009749009097066. Scand J Rheumatol Suppl. 1990. PMID: 2175452 Review. No abstract available.
Cited by
-
Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantation.PLoS One. 2013 Jul 26;8(7):e68663. doi: 10.1371/journal.pone.0068663. Print 2013. PLoS One. 2013. PMID: 23922659 Free PMC article.
-
Outcomes among pediatric heart transplant recipients.Tex Heart Inst J. 1997;24(2):97-104. Tex Heart Inst J. 1997. PMID: 9205982 Free PMC article.
-
Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders.Cells. 2022 Nov 2;11(21):3476. doi: 10.3390/cells11213476. Cells. 2022. PMID: 36359871 Free PMC article. Review.
-
Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients.BMC Nephrol. 2021 Mar 20;22(1):102. doi: 10.1186/s12882-021-02285-2. BMC Nephrol. 2021. PMID: 33743617 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials